Brief: Helix BioPharma Corp director resigns
17/07/2017 12:00
July 17 (Reuters) - Helix Biopharma Corp HBP.TO
* Helix BioPharma says board has accepted Albert Beraldo's
resignation as director of company and audit committee chair,
effective July 14, 2017
Source text for Eikon: ID:nMKWhQfWfa
Further company coverage: HBP.TO
((Bangalore.newsroom@thomsonreuters.com; ;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020